Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
Carregando...
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.73, article ID UNSP e210, 5p, 2018
Resumo
OBJECTIVES: To describe the perinatal outcomes of type II and III selective fetal growth restriction (sFGR) in monochorionic-diamniotic (MCDA) twin pregnancies treated with expectant management or laser ablation of placental vessels (LAPV). METHODS: Retrospective analysis of cases of sFGR that received expectant management (type II, n=6; type III, n=22) or LAPV (type II, n=30; type III, n=9). The main outcomes were gestational age at delivery and survival rate. RESULTS: The smaller fetus presented an absent/reversed ""a'' wave in the ductus venosus (arAWDV) in all LAPV cases, while none of the expectant management cases presented arAWDV. The median gestational age at delivery was within the 32nd week for expectant management (type II and III) and for type II LAPV, and the 30th week for type III LAPV. The rate of at least one twin alive at hospital discharge was 83.3% and 90.9% for expectant management type II and III, respectively, and 90% and 77.8% for LAPV type II and III, respectively. CONCLUSION: LAPV in type II and III sFGR twins with arAWDV in the smaller fetus seems to yield outcomes similar to those of less severe cases that received expectant management.
Palavras-chave
Twin Pregnancy, Monochorionic Pregnancy, Selective Fetal Growth Restriction, Expectant Management, Laser Ablation of Placental Vessels, Perinatal Outcomes
Referências
- Machado RDA, 2014, REV ASSOC MED BRAS, V60, P585, DOI 10.1590/1806-9282.60.06.019
- Buca D, 2017, ULTRASOUND OBST GYN, V50, P559, DOI 10.1002/uog.17362
- Gratacos E, 2008, ULTRASOUND OBST GYN, V31, P669, DOI 10.1002/uog.5362
- Gratacos E, 2007, ULTRASOUND OBST GYN, V30, P28, DOI 10.1002/uog.4046
- Ishii K, 2009, FETAL DIAGN THER, V26, P157, DOI 10.1159/000253880
- Khalil A, 2016, ULTRASOUND OBST GYN, V47, P247, DOI 10.1002/uog.15821
- Lewi L, 2008, AM J OBSTET GYNECOL, V199
- Lewi L, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.009
- Liao AW, 2012, CLINICS, V67, P451, DOI 10.6061/clinics/2012(05)08
- Lopriore E, 2012, PLACENTA, V33, P171, DOI 10.1016/j.placenta.2011.12.004
- Parra-Cordero M, 2016, FETAL DIAGN THER, V39, P186, DOI 10.1159/000439023
- Peeva G, 2015, FETAL DIAGN THER, V38, P86, DOI 10.1159/000374109
- Quintero RA, 2001, AM J OBSTET GYNECOL, V185, P689, DOI 10.1067/mob.2001.116724
- Rustico MA, 2017, ULTRASOUND OBST GYN, V49, P387, DOI 10.1002/uog.15933
- To MS, 2001, ULTRASOUND OBST GYN, V17, P217, DOI 10.1046/j.1469-0705.2001.00369.x
- Valsky DV, 2010, SEMIN FETAL NEONAT M, V15, P342, DOI 10.1016/j.siny.2010.07.002
- Visentin S, 2013, J PERINAT MED, V41, P309, DOI 10.1515/jpm-2012-0133